Genomic Vision announced that its new integrated software FiberSmart® has been successfully tested and validated by AstraZeneca, and the Fritz Lipmann Institute, Germany for the analysis of Replicating Combing Assay (RCA). FiberSmart® is an innovative, AI-based suite aimed at automating the detection and quantification of fluorescent signals on combed DNA molecules. Hundreds of thousands of RCA signals are automatically analyzed and rapidly compared while the end-user enjoys a seamless experience.

The RCA is Genomic Vision's proprietary method for the direct visualization of DNA replication kinetics at the single molecule level. FiberSmart® has a simple and user-friendly interface, allowing users to quickly analyze DNA replication signals, deducing kinetics. RCA is the first assay to be analyzed and automated with the FiberSmart® software.

It leverages AI methods to visualize, detect and analyze DNA replication kinetics up to three times more accurately and up to ten times faster than Genomic Vision's existing software solutions. The software is compatible with Genomic Vision's suite of scanners FiberVision® and FiberVision-S®. FiberSmart® for the RCA application will be launched in the coming weeks.